Uutta toivoa suuren riskin pahanlaatuista ihosyöpää sairastaville potilaille

BestPractice | SYYSKUU 20, 2017 |

Tuore tutkimustieto antaa uutta toivoa potilaille, joilla on suuren riskin pahanlaatuinen ihosyöpä. Asiantuntijana apulaisprofessori Karl Lewis, Colorado Denver School of Medicine –yliopisto, USA.

#

Uutta tietoa

Potentiale as standard of care for patients with relapsed/refractory multiple myeloma
Potentiale as standard of care for patients with relapsed/refractory multiple myeloma
Click and hear Paul G. Richardson present the data for...
Promising activity for late-stage patients with relapses/refractory multiple myeloma
Promising activity for late-stage patients with relapses/refractory multiple myeloma
Despite recent advances in MM therapy, the disease remains incurable....